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Class V myosins are multifunctional molecular motors implicated in vesicular traffic, RNA transport, and mechanochemical coupling of
the actin and microtubule-based cytoskeletons. To assess the function of the single myosin V gene in Drosophila (MyoV), we have
characterized both deletion and truncation alleles. Mutant animals exhibit no detectable defects during embryogenesis but are delayed in
larval development; most die prior to 3rd instar. MyoV protein is widely distributed; however, there are no obvious cytological defects in
mutant larval tissues where MyoV was normally highly expressed. Of the few adult MyoV mutant escapers, females were fertile but males
were not. We examined the expression of MyoV during spermatogenesis. MyoV was associated with membranes, microtubule, and actin
structures required for spermatid maturation; MyoV was strongly associated with the sperm nuclei during the maturation of the actin-rich
investment cones that package spermatids in individual membranes. In MyoV mutant escaper males, the early stages of spermatogenesis were
normal; however, in the later stages, the investment cones stained weakly for actin and their registration was disrupted; no mature sperm were
produced. Our results suggest that MyoV contributes to the formation of the actin-based investment cones and acts to coordinate and/or
anchor these structures and other components of the individualization complex.
D 2005 Elsevier Inc. All rights reserved.Keywords: Actin; Microtubules; Investment cones; Individualization complex; Gut; Oogenesis; CNSIntroduction
The biochemical and biophysical properties of the class
V myosins have been extensively characterized (Vale,
2003). Additionally, a broad range of cellular functions
has been identified for class V myosins, and a given myosin
V can serve multiple functions (Mermall et al., 1998; Reck-
Peterson et al., 2000; Wu et al., 2000). For example, Myo2p
in Saccharomyces cerevisiae serves essential functions in0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.07.028
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E-mail address: lynn.cooley@yale.edu (L. Cooley).secretion and cell polarity (Johnston et al., 1991), parti-
cipates in spindle orientation (Beach et al., 2000; Yin et al.,
2000), and inheritance of several types of organelles
including Golgi (Govindan et al., 1995; Rossanese et al.,
2001), vacuoles (Hill et al., 1996), mitochondria (Itoh et al.,
2002), and peroxisomes (Hoepfner et al., 2001). The other
yeast class V myosin, Myo4p, participates in mRNA
transport and localization (Long et al., 1997; Munchow et
al., 1999) as well as inheritance of the endoplasmic
reticulum (Estrada et al., 2003).
In metazoan species, an equally diverse range of
functions has been identified. Class V myosins are
associated with multiple cargoes and binding partners;
many of which interact with the tail domain of myosin V.86 (2005) 238 – 255
Table 1
Complementation groups and stocks used in the study
Allele or stock Source
Df(2R)Drlrv22 Umea center
CyO P[w+act5CGFP] Bloomington center
+/+;Sp/CyO;D2-3Sb/TM6 Cooley Lab
w;P[w+FRT]2RG13L/CyO Cooley Lab
+;P[w+FRT]2rG13P[OvoD1]/CyO Cooley Lab
yw,P[ry+hsFLP]12;CyO/Sco Cooley Lab
CyO/Sco Cooley Lab
w;CyO,TM6C/Xa Cooley Lab
l(2)k10009 Istvan Kiss, Hungary
ry506P{PZ}jar1/TM3,ryRK,Sb1Ser1 Bloomington center
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smooth ER (Tabb et al., 1998), brain vesicles (Evans et
al., 1998; Miller and Sheetz, 2000; Prekeris and Terrian,
1997), pigment granules (Wu et al., 1998a; Wu et al., 2002),
membrane recycling vesicles (Lapierre et al., 2001), and the
post-synaptic density of dendrites (Wang et al., 1996), as
well as cytoskeletal elements such as microtubules (MT)
(Cao et al., 2004; Waterman-Storer et al., 2000), the MT
motor, kinesin (Hara et al., 2000; Rogers and Gelfand, 1998;
Stafford et al., 2000), the 8k dynein light chain (Espindola et
al., 2000), and intermediate filaments (Bridgman, 1999; Rao
et al., 2002). Recently, myosin Va and Rab27 were shown to
be associated with vesicles at the acroplaxome in rat
spermatids. This F-actin-containing structure is found
between the acrosome and spermatid nucleus and may play
a role in vesicle transport required for acrosome biogenesis
(Kierszenbaum et al., 2003a).
In Drosophila there is a single myosin V gene (MyoV or
didum) (Bonafe´ and Sellers, 1998; MacIver et al., 1998) that
is expressed throughout the lifetime of a fly. In this study,
we describe the developmental profile of Drosophila MyoV
protein expression and localization, revealing a large array
of tissues expressing MyoV. We also describe two func-
tional null mutations: one deletion and one truncation of the
tail domain. Both mutants result in a high frequency of
larval lethality revealing that MyoV is an essential gene. To
our surprise, the actin-based cytoskeleton is not grossly
affected in the mutants, nor is MyoV function required
during either oogenesis or embryogenesis. However, MyoV
is required for spermatogenesis. We examined the morphol-
ogy and distribution of cytoskeletal and membrane compo-
nents in MyoV mutant testes. We report that MyoV is
required for sperm individualization, specifically for the
formation of actin-rich investment cones and their spatial
relationship to sperm heads. These results shed light on the
potential function of MyoV as a coordinator of membrane,
microtubule, and actin systems.Materials and methods
Drosophila stocks
All fly stocks were maintained under standard culture
conditions. The stocks used in this study and their origins
are summarized in Table 1.
Screening of the Szeged collection
The Szeged collection of lethal insertions of a P[lacW]
transposon on the 2nd chromosome (Torok et al., 1993) was
analyzed for the presence of a P element in or near the
MyoV (didum) gene by screening plasmids rescued from
insertion lines (Guo et al., 1996) with a 1.13-kb cDNA clone
from the 5V end of the Drosophila MyoV open reading frame
(Bonafe´ and Sellers, 1998). The screening procedure,performed in the laboratory of Kim Kaiser (University of
Glasgow, Glasgow, UK), isolated the rescued plasmid
P1440, corresponding to the insertion in the fly strain
l(2)k10009 (Istvan Kiss, Institute of Genetics, Biological
Research Centre of Szeged, Hungary). l(2)k10009 failed to
complement the Df(2R)Drlrv22 deficiency, which also
deletes the MyoV gene as shown by immunoblot analysis
(Fig. 1C). Sequencing of the isolated plasmid positioned the
insertion 76-bp 5V of the dpa ATG codon (Fig. 1A). To
establish that l(2)k10009 is a dpa allele, we rescued the
insertion mutation with a P[dpa] transgene (Feger et al.,
1995).
P element excision strategy
To obtain a deletion of the MyoV gene, the P element in
l(2)k10009 was mobilized by standard methods (Robertson
et al., 1988) and w revertants were tested by complemen-
tation with Df(2R)Drlrv22/CyO,P[w+act5CGFP]. The
nature of the deletions was characterized by Southern blot
analysis of genomic DNA with probes indicated in Fig. 1.
Germline transformations
A 12-kb EcoRI fragment of genomic DNA containing
the entire dpa transcription unit cloned into the trans-
formation vector pCaSpeR4 (kindly provided by George
Feger, SPRI, Geneva, Switzerland) (Feger et al., 1995) was
transformed into w1118 embryos by standard techniques
(Spradling, 1986). Three transformation lines were estab-
lished and crossed to l(2)k10009 to assay for rescue of the
recessive lethality.
To construct a genomic MyoV transposon, we screened a
NotBamNot-CoSper cosmid library (generous gift from
Thomas Hays, University of Minnesota, St. Paul, MN),
usingMyoV cDNAs previously described (# a1; Bonafe´ and
Sellers, 1998). Three genomic clones, identified by South-
ern analysis, contained the full-length MyoV gene. Cosmid
#3 was chosen as template for PCR amplification of the
MyoV transcription unit. A 3.11-kb PCR1 product spanned
from a created BamH1 restriction site, 5V to the ATG of the
open reading frame up to the unique SpeI restriction site
located in the middle of the gene. A 4.41-kb PCR2 product
Fig. 1. Genomic organization and protein expression of myosin V (MyoV).
(A) The genomic organization of MyoV consists in 17 exons and 16
introns, with the 5V and 3V untranslated regions indicated by light grey. This
gene structure corresponds to didum-RA in Flybase (www.Flybase.net). The
region eliminated in deletion 28 (del28) is shown above; the P element
l(2)k10009 inserted in the 5VUTR of the dpa gene is shown below. Bottom:
Probes I, II, and III used in Southern analysis. (B) Predicted domain
structure of Drosophila MyoV heavy chain and of the truncated form
produced by the MyoVQ1052st allele. The head domain spans the amino acid
residues 1–771 at the N-terminus. The neck domain, or regulatory domain
(IQ), is composed of 6 IQ motifs (residues 772–910). The tail domain is
composed of a series of coiled-coil segments (cc) that allow dimerization
and a predicted globular tail domain. MyoVQ1052st is a non-sense mutation
at Gln 1052 (CAG-to-UAG) in the first coiled-coil motif. (C) MyoV is
specifically recognized (MV, lane 1) in Drosophila extracts by immunoblot
blot analysis. An equally loaded blot was probed with the polyclonal
antiserum directed against the tail domain of MyoV (amino acid residues
976–1753). The antibody did not recognize the truncated form of MyoV
(lane 2), confirming the absence of the corresponding domain in the mutant
protein. MyoV expression is reduced about 2-fold in Df(2R)Drlrv22/CyO
flies compared to w1118 and Sco/CyO controls. Myosin III (ninaC) is shown
as a loading control. (D) An immunoblot of staged embryos, larvae, pupae,
adults, Schneider’s cells (50 Ag/lane), and testes (1 Ag/lane) was probed
with myosin V affinity-purified polyclonal antibodies (¨2 Ag/ml). MyoV
(207 kDa) is detected at every stage of development. The level of
expression slightly increases in late embryos. In adults, MyoVexpression is
variable but is prominent in the head (brain/eyes), the gut, ovaries, and
testes.
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following the stop codon of the reading frame. Each PCR
product was subcloned and sequenced. A single T to C
mutation responsible for an isoleucine/threonine change at
amino acid 1566 was found in the PCR2 construct and was
not corrected. The BamH1/SpeI and SpeI/XbaI fragments
were cloned into the BamH1/XbaI sites of pUB vector(Hudson and Cooley, 2002). The w1118 embryos were
transformed and five lines established, two of which were
used for rescue tests.
EMS Mutagenesis
Isogenic pr cn bw;e males were treated with ethyl
methane sulfonate (EMS) (25 mM) as previously described
(Lewis and Bacher, 1968) and crossed to +/Xa females.
About 2000 F1 male progeny were individually crossed to
virgin hts1, kel1/CyO;cherD12/TM6C females. 850 single
males from the viable crosses were further tested for
complementation with Df(2R)Drlrv22. The 13 lines that
failed to complement were crossed to Df(2R)Drlrv21,
Df(2R)NCX5, soD, del27, del28, and l(2)k10009. One line,
#8, failed to complement both the del28 deletion and the
larger deletion Df(2R)Drlrv21 and fully complemented
l(2)k10009. Therefore, line # 8 was a good candidate for a
MyoV mutation. To remove extraneous lethal mutations,
w;pr cn bw #8/CyO males were crossed to Canton S females
and three independent cn #8 recombinants were isolated.
One line was successfully rescued with one copy of the
MyoV transgene and was further sequenced.
Sequencing of the MyoV genomic transcription unit
The entire MyoV gene sequence was deduced from P1
clone DS01142 (accession number AC004289); it ranges
from nucleotide 58125 to nucleotide 66650. DNA from
the line #8 mutant chromosome was PCR amplified using
a series of primers spanning the whole gene and sequenced
(W.M. Keck Foundation Biotechnology Resource Labora-
tory, Yale University). Both strands were analyzed and
every fragment was amplified and sequenced in dupli-
cate. After sequencing, the EMS mutant was renamed
MyoVQ1052st.
RT-PCR
RNA was isolated from MyoVQ1052st/CyO, GFP, and
MyoVQ1052st/MyoVQ1052st 1st and 2nd instar larvae with
RNAeasy Mini (Qiagen). RT-PCR was performed with
Superscript III One-Step (Invitrogen Corp., Carlsbad, CA)
using primers 5VGCCACTATGCACACCTACCTACTG3V
and 5VCAGCACTCCCAAGCGAGATT3V. The PCR product
extends from cDNA base pairs 790–1618 and encompasses
two introns of genomic DNA (if present). Amplification
products were analyzed by agarose gel electrophoresis.
Hatch rate and developmental time course
MyoVQ1052st/CyO,GFP flies were maintained in an egg
collection jar with fresh apple juice/yeast plates for several
days at room temperature. A fresh collection plate was
provided and flies were allowed to lay eggs for 4 h. 400
eggs were collected and sorted for the presence of the GFP
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dissecting microscope (Olympus America, Inc., Melville,
NY). After hatching, non-fluorescent homozygous mutant
and fluorescent heterozygous larvae were separated and
transferred to fresh and scored for developmental stage by
anterior spiracle morphology (Ashburner, 1989). The
homozygous mutants were followed through eclosion; the
CyO,GFP controls were discarded as pupae. Animals were
scored as dead only if the carcass could be recovered, and as
lost if there was no other account. These data are combined
for simplicity. Photographs were taken through the dissect-
ing microscope, scanned, and processed with Photoshopi
(Adobe Systems Incorporated, San Jose, CA).
Gut pH and food clearance
Gut pH and food clearance was assessed by feeding pH
indicator dyes or fast green in yeast paste (Dubreuil et al.,
1998). The color of the pH indicators was photographed
immediately after dissection in glycerol with a Nikon E800
microscope (Nikon USA, Melville, N.Y.) equipped with a
Spot CCD camera (Diagnostic Instruments Incorporated,
MI), courtesy of Weimin Zhong, Yale University.
Phototaxis
We assessed the negative phototaxic response of larvae
by a modification of the method of Sawin-McCormack et al.
(1995). Instead of the quadrant mask used, we used a 16
square checkerboard pattern on 60  15 mm Petri dishes.
Germline clone analysis
Germline clone analysis was performed using the FRT/
FLP recombinase method (Golic, 1991; Golic and Lindquist,
1989) together with the ovoD1-Dominant Female Sterile
technique (Chou et al., 1993). A P[w+FRT]2RG13,
MyoVQ1052st chromosome was made by recombination and
crossed to males carrying yw,P[ry+hsFLP]12 on the X
chromosome and the corresponding P[w+FRT]2RG13,ovoD1
on the second chromosome. The 0- to 24-h eggs were
collected, and second instar stage larvae were heat shocked to
induce expression of the FLP recombinase. Ovaries were
examined and clones were identified by the presence of
vitellogenic egg chambers and mature eggs.
Production of MyoV tail domain antibody
A cDNA clone #C4 covering 2.3 kb of the 3V end of the
MyoV coding region (nucleotides 2998–5329 in AF003826)
(Bonafe´ and Sellers, 1998) was subcloned into the EcoRI
site of expression vector pET30a (Novagen, EMD Bio-
sciences, Inc., San Diego, CA). BL21 (DE3) cells (Stra-
tagene, La Jolla, CA) were transformed with the construct
and induced at 30-C for 2–3 h with 0.2 mM IPTG. The
resulting (his)6 fusion protein of 94 kDa contained most ofthe tail domain (amino acids 976–1753). Inclusion bodies
containing the insoluble protein were purified using the B-
PER buffer (Pierce, Rockford, IL), and resuspended in
25mM Tris–HCl pH 8.0, 5mM EDTA, 1.5% sarkosyl
supplemented with a cocktail of protease inhibitors.
Following homogenization, the protein sample was centri-
fuged at 30,000g for 20 min in a TL100 tabletop
ultracentrifuge (Beckman Coulter, Inc., Fullerton, CA).
The supernatant containing the soluble protein was sub-
sequently used as antigen for antibody production in rats
and as ligands for Ni2+ affinity chromatography (Novagen,
San Diego, CA) to purify the polyclonal antibodies. The
purified antibodies were diluted to a final concentration
ranging from 1.5 to 2.5 Ag/ml for immunoblotting, and 5–8
Ag/ml for immunocytochemistry.
Immunoblot
Twenty freshly removed fly heads were homogenized in
80 Al of sample buffer (5% SDS, 62.5 mM Tris–HCl, pH
6.8, 2% h-mercaptoethanol, 10% sucrose), and protein from
about 4 heads was loaded on a 7.5% SDS–PAGE gel,
electrophoresed, and transferred to Immobilon-P membrane
(Millipore Corp., Billerica, MA). Anti-MyoV affinity-
purified antibodies were used at 1.5–2.5 Ag/ml, and
antibodies recognizing p132 myosin III isoform of NinaC
were used at 1:10,000 (generous gift from Craig Montell,
The Johns Hopkins University, Baltimore, MD) (Porter et
al., 1992). Immunoblot processing and chemiluminescence
protein detection were performed according to the manu-
facturer’s instructions (ECL detection system, Amersham
Bioscience, Piscataway, NJ) using horseradish peroxidase-
conjugated secondary antibodies (Boehringer-Mannheim-
Roche, Indianapolis, IN).
Drosophila embryos, larvae, pupae, and adult tissues
were processed for immunoblotting using a trichloracetic
acid (TCA) precipitation method. Staged embryos were
collected, rinsed with a solution of 0.1% Triton X-100/150
mM NaCl, dechorionated for 2–3 min in 50% bleach,
washed again in 0.1% Triton X-100/150 mM NaCl, and
finally homogenized in 200 Al of ice-cold 5% TCA.
Dissected adult heads, larval guts, and ovaries, as well as
whole larvae, pupae, or S2 cells, were washed in ice-cold
PBS prior to homogenization in 200 Al of ice-cold 5% TCA.
After removal of an aliquot for protein quantification (Bio-
Rad Laboratories, Hercules, CA), the remainder of the
precipitates was pelleted, dried, washed with acetone, dried,
and resuspended in boiling SDS gel sample buffer. Fifty
micrograms of total protein was loaded per lane, electro-
phoresed and blotted as described above.
Immunostaining procedures
Ovaries were dissected, fixed, and processed as previ-
ously described (Cant et al., 1994; Robinson and Cooley,
1997). For actin staining, dissected egg chambers were
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0.5% BSA) containing 2 units of rhodamine-conjugated
phalloidin (Molecular Probes, Eugene, Oregon) overnight at
4-C, then rinsed in PBT. For antibody staining, tissue was
blocked in PBT for 1–2 h at room temperature, and then
overnight at 4-C with purified rat anti-MyoVantibody at 5–
8 Ag/ml. Egg chambers were washed with PBT prior to
incubation for 2 h at room temperature with FITC-
conjugated goat anti-rat IgG secondary antibody (Boeh-
ringer-Mannheim-Roche) diluted 1:100 in PBT containing
10% normal goat serum (NGS). Samples were mounted in
antifade (90% glycerol, 10% phenylenediamine (antifade,
Sigma)) and viewed on an LSM-510 confocal microscope
(Carl Zeiss, Inc, Thornwood, NY) (Center for Cell Imaging,
Yale University School of Medicine); images were pro-
cessed with Graphic Converteri (Lemke Software GmbH,
http://www.lemkesoft.com/) and Adobe Photoshop i.
Gut and CNS tissues from w1118 or MyoV mutant 1st
instar larvae were dissected and fixed in 1 PBS, 2%
paraformaldehyde, 20 mM EDTA. Tissues were rinsed
several times with PBS and permeabilized with 0.2% Triton
X-100 in PBS for 15 min. They were then blocked with
25% NGS in PBT for 1 h and incubated with rat anti-MyoV
antibodies at 4.5 Ag/ml in 5% NGS in 0.05% Tween 20, 50
mM Tris, 150 mM NaCl, pH 8 (TBST) overnight at 4-C.
Following TBST washes, the samples were incubated in 1/
200 Alexa 488 goat anti-rat antibodies (Molecular Probes)
in 5% NGS, TBST for 1 h, and washed with TBST. When
costained for actin, rhodamine–phalloidin at 1/200 (Molec-
ular Probes) was added to the first 10-min wash. Samples
were mounted in Citifluor (Ted Pella, Inc., Redding, CA)
and viewed on a Bio-Rad 1024 confocal microscope (Bio-
Rad Laboratories).
Testes from young adult flies were dissected in Droso-
phila Ringer’s (Ashburner, 1989) and fixed in 4% para-
formaldehyde for 30 min. Tissues were rinsed several times
with TBST and permeabilized with 0.3% Triton X-100, and
0.3% deoxycholate in 50 mM Tris (pH 8), 150 mM NaCl for
1 h. After a brief rinse with TBST, testes were blocked with
3% bovine serum albumin for 1 h. Affinity purified rat anti-
Drosophila MyoV (5 Ag/ml), anti-Drosophila MVI (1:10,
mAb 3C7; Kellerman and Miller, 1992; kind gift of K.G.
Miller, Washington University, St. Louis, MO), and anti-a
tubulin antibody (1:200, Sigma-Aldrich, St. Louis, MO)
were applied in block overnight at 4-C. Following TBST
washes, the samples were incubated in Alexa 488 goat anti-
rat antibodies (Molecular Probes) in block for 1 h and
washed. When costained for actin, rhodamine–phalloidin or
Alexa Fluor 350 phalloidin at 1/200 (Molecular Probes) was
added to the secondary antibody. Nucleic acids were
visualized with OliGreen\ (Molecular Probes) at 1:2000.
Membrane was visualized with Alexa 594 concanavalin A
(Molecular Probes). Cysts treated with colchicine (40–50
AM for 1 h) were handled as described (Noguchi and Miller,
2003). Samples were mounted in Citifluor (Ted Pella, Inc.,
Redding, CA) and viewed on a Bio-Rad 1024 confocalmicroscope (Bio-Rad Laboratories, Hercules, CA) or a
Nikon Diaphot 300 (Nikon, Melville, NY) equipped with a
Coolsnap HQ CCD camera (Photometrics, Tucson, AZ).Results
Identification of mutations in MyoV
Genomic and cDNA sequence alignments led to the
establishment of the MyoV gene physical map consisting of
17 exons and 16 introns (Fig. 1A). The computational gene
model for MyoV (www.flybase.net) predicts 3 different
transcripts, with didum-RA corresponding to our gene
structure. We pursued a multistep strategy to generate
mutant alleles of MyoV.
To isolate a deletion allele of MyoV, we mobilized the P
element in l(2)k10009 (628 bp 5V of the starting ATG codon
of MyoV; Fig. 1A) and screened for imprecise excision. We
generated 31 lethal excision lines that failed to complement
the lethal phenotypes of both Df(2R)Drlrv22 (which
removes MyoV) and l(2)k10009. One of these, del 28
(Fig. 1A), affected MyoV based on Southern blot analysis
(data not shown, see Materials and methods). However,
transgene rescue tests demonstrated that the mutation was
affecting both the dpa and MyoV genes. Neither a P[dpa]
genomic transgene nor a P[MyoV] transgene alone could
rescue the del 28 mutant lethal phenotype. However, the
combination of the two could rescue the mutant to full
viability and fertility. Immunoblot analysis confirmed a 2-
fold reduction of MyoV protein in flies heterozygous for del
28 chromosome (data not shown), as shown in flies
heterozygous for the Df(2R)Drlrv22 deficiency (Fig. 1C),
demonstrating that del 28 is null for MyoV.
In order to isolate point mutations in MyoV, we per-
formed an EMS screen (N. Sokol and L. Cooley, unpub-
lished). 850 lines were tested for complementation with the
Df(2R)Drlrv22 deletion. The 13 lines that failed to comple-
ment the deficiency were further tested for complementa-
tion with a larger deficiency Df(2R)Drlrv21, del28, and
l(2)k10009, a dpa allele. Line #8 failed to complement both
Df(2R)Drlrv21 and del28, but complemented the dpa allele.
In addition, line #8 could be rescued with the P[MyoV]
transgene. These results demonstrate that line #8 contained a
MyoV mutation.
Sequence analysis of the MyoV gene in line #8 revealed a
CAG-to-UAG change that is predicted to introduce a stop
codon at residue Gln1052. The allele was designated
MyoVQ1052st. Translation termination at the non-sense
mutation should truncate the protein-heavy chain in the
first coiled-coil motif (Fig. 1B). If expressed, the molecule
may retain sufficient coiled-coil structure to support
dimerization. MyoVQ1052st homozygous animals were ana-
lyzed by immunoblot blot using the antibody to the tail
domain; neither wild-type nor truncated protein was
detected in the mutant lane (Fig. 1C, lane 2). No antibodies
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protein; therefore, we performed RT-PCR on RNA from
MyoVQ1052st homozygous and balanced heterozygous larvae
using primers against the head domain of MyoV. cDNA
from the MyoV head domain was detected in both control
and mutant animals (data not shown); however, as discussed
below, if produced the truncated protein is unlikely to be
functional.
MyoV mutants have delayed post-embryonic development
and increased larval death
To characterize the effect of the MyoVQ1052st mutation on
embryonic development, we first determined the hatch rate
of larvae. MyoV mutant embryos hatched at a rate of 20.5%
(82 of 400 eggs) compared to an expected rate of 25%; of
the unhatched eggs, 3.5% (14 of 400) could be identified as
MyoV mutants. These data show that females laid MyoV
mutant eggs at a normal rate and that the expected number
hatched.
To further understand the mutant phenotype, larval
lethality was examined. MyoVQ1052st/CyO,GFP balanced
heterozygous control larvae (Fig. 2, top panel) and
homozygous MyoVQ1052st larvae (Fig. 2, bottom panel)Fig. 2. MyoVQ1052st mutation delays larval development and increases
larval death. Homozygous MyoVQ1052st mutant larvae (mutants) and
balanced heterozygous larvae (MyoVQ1052st/CyO-GFP controls) were
followed after hatching and scored for developmental stage; graphs
summarize the data. For the first 2 days after hatching, both mutant and
control larvae are similar in development. By day 3 most of the controls
have molted to 3rd instar, but the mutants lag behind and begin to die. By
day 6, over 60% of the controls have pupated; but nearly half of the mutant
larvae have died. The remainders are still in the 2nd and 3rd instar stage.
The mutant larvae do not start to pupate until day 9, with less that 10%
pupating.were scored for developmental phase. For the first 2 days
after hatching, there was no visible effect on larval
development in mutant animals, both in terms of numbers
and phenotypes. While most control animals molted to third
instar by day 3, the length of the second instar of
development was expanded in mutants; mutant third instars
began to appear at day 5. By day 3, control animals were
larger than mutants. The appearance of mutant third instars
also corresponded with increased numbers of dead animals.
By day 7, over 60% of the controls pupated, but over half of
the mutant larvae died. For the surviving mutant animals,
the third instar was lengthened from the wild-type period of
about 2 days to about 4 days. The mutant larvae were
delayed in pupation (Fig. 2, day 6). They began to pupate at
day 9, with less than 10% pupating. After 2 weeks a few
adults eclosed (less than 10%); however, 90% of the
mutants died or were lost (54% dead, 38% lost; lost larvae
may have escaped from the plate). This is in sharp contrast
to the controls in which over 70% pupated and only 28%
died or were lost (17% dead, 11% lost). These data show
that the lethal phase of MyoVQ1052st occurs during third
instar development, with very few animals surviving to
pupariate.
We followed homozygous MyoVQ1052st mutants, homo-
zygous del28 mutants carrying a P[dpa] transgene, and
hemizygous MyoVQ1052st/del28 mutants through develop-
ment. Interestingly, they all exhibited the same phenotype,
characterized by the lethal phase and the developmental
larval delays shown for MyoVQ1052st in Fig. 2. This result
indicates that the phenotype observed in the truncation
mutation is not due to the dominant-negative effects of
tailless MyoV protein expression; rather, the MyoVQ1052st
mutation acts as a null.
MyoV was ubiquitously expressed throughout development
Expression of MyoV was first examined by immunoblot
analysis of staged wild-type embryos, larvae, pupae, and
adults (Fig. 1D). The protein was detected at all stages of
development including early stage embryos, most likely due
to high levels of maternally contributed MyoV transcripts
(Bonafe´ and Sellers, 1998). MyoV protein expression
increased throughout embryonic development and appeared
constant during larval development. In adults, MyoV was
particularly abundant in the head (at least 10-fold of larval
levels), but was also found in the gut, ovaries, and testes.
Given the high level of MyoV expression in the adult
head, we examined MyoV localization in the eye (Supple-
mentary Fig.1). MyoV staining was found throughout the
ommatidia but concentrated in a region below the pseudo-
cone. Punctate MyoV staining was also found at the base of
the actin-rich rhabdomeres. Actin staining of MyoVQ1052st
mutant eyes revealed normal rhabdomere structure and adult
mutant flies exposed to light appeared to display normal
phototaxic behavior; additionally, no difference in negative
phototaxic behavior was seen in the MyoVQ1052st mutant
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in rhabdomere development or photoreception.
In larvae, MyoV was found in the brain hemispheres and
the midline and lateral regions of the ventral ganglion
(Supplementary Fig. 2A). Although highly expressed in the
CNS, no obvious defects in neuronal cell fate determination
were observed in the MyoV mutant (C. Doe, unpublished
observations).
MyoV was abundantly expressed in the digestive system
(Supplementary Fig. 2), most strongly expressed in anterior
midgut structures. Strong expression continued in the mid-
midgut to the posterior midgut (Supplementary Fig. 2D–I).
Less intense MyoV staining was found in the posterior
midgut, and in Malpighian tubules; however, more intense
staining was apparent in the ureter that connects the
Malpighian tubules to the midgut/hindgut junction (Supple-
mentary Figs. 2J and K); lack of MyoV stain in ureter from
MyoVQ1052st animals confirmed the antibody specificity
(Supplementary Fig. 2L).
MyoV was highly expressed in larval secretory tissues
(Supplementary Figs. 2B, C, and F). Strong, punctate MyoV
staining was found in the gastric caecea, salivary glands,
proventriculus, and the copper cells. Throughout the
midgut, MyoV staining was punctuate and subapical to
the luminal actin staining. This pattern of MyoV distribution
was seen in all the digestive tissues examined. The punctate,
sub-cortical distribution of MyoV suggests that this motor
may be associating with membranous or vesicular struc-
tures. However, none of these tissues with MyoVexpression
in wild-type animals had a defect visible by light micro-
scopy. Moreover, food clearance (see Materials and me-
thods) and pH regulation by the copper cells (see Materials
and methods) both appeared normal in Myo5 mutant larvae
(data not shown).
MyoV is expressed in the female germline but is not required
for oogenesis
Immunostaining of wild-type egg chambers revealed that
MyoV is present in the cytoplasm of somatic and germ cells
beginning at ¨ stage 5 of oogenesis (Supplementary Fig. 3).
The protein accumulated in the oocyte and became enriched
subcortically. Double staining of egg chambers for MyoV
and actin revealed a strong co-localization of MyoV with
the cortical actin network in the nurse cells, the oocyte and
the follicle cells, but not with cytoplasmic actin filament
bundles at stage 10B of oogenesis (data not shown).
When virgin females producing MyoVQ1052st germline
clones were crossed to w;del28/CyO,GFP males, non-
balanced MyoVQ1052st/del28 mutant animals hatched and
developed through second to third instar larvae, as was seen
for homozygousMyoVQ1052st mutants or homozygous del28
mutants rescued with the P[dpa] transgene (P[dpa];del28/
del28). Similarly, rare escaper MyoVQ1052st homozygous
mutant virgin females were crossed to MyoVQ1052st/
CyO,GFP males and produced viable offspring. However,escaper homozygous MyoVQ1052st mutant males were
sterile. These data clearly demonstrate that MyoV is not
required for oogenesis or embryogenesis but may play an
essential role during spermatogenesis.
MyoV was required for male fertility
To establish the extent of male MyoV mutant infertility
we crossed forty-two homozygous MyoVQ1052st males to an
equal number of balanced MyoVQ1052st/CyO,GFP virgin
females in small groups. Matings were observed and eggs
were laid; however, no eggs hatched. Control crosses
between balanced males and females always produced
larvae. To confirm that the infertility was due to the MyoV
mutation and not a cryptic mutation on the MyoVQ1052st
chromosome, we tested fertility of del28 males carrying the
P[dpa] transgene to rescue dpa. P[dpa];del28/MyoVQ1052st
males were crossed to balanced virgin (P[dpa];del28/
CyO,GFP or MyoVQ1052st/CyO,GFP) females; no offspring
resulted from these crosses confirming that MyoV is
required for male fertility.
MyoV mutants do not produce mature sperm
The late stages of spermatogenesis in Drosophila
require the coordinated activity of actin, MTs, membranes,
myosin VI, and many other components regulating actin
dynamics (Rogat and Miller, 2002). A series of mitotic
and meiotic cell divisions produces a syncytial cyst of 64
immature spermatids. These spermatids elongate the length
of the testes and then undergo a process of post-elongation
maturation that includes fully condensing their DNA,
elongating the acrosome, as well as changes to the
axoneme and major mitochondrial derivative (Lindsley
and Tokuyasu, 1980). In immature, fully extended cysts,
the nuclei are in the terminal or basal region of the testes.
In order to produce mature sperm, each spermatid must be
invested in an individual membrane and excess cytoplasm
removed. This is accomplished during the process of
individualization by an individualization complex contain-
ing 64 actin-based investment cones (Fabrizio et al., 1998;
Tokuyasu et al., 1972a). In addition to actin, each
investment cone contains a number of proteins that
interact with actin including myosin VI (jaguar), Arp2/3,
cortactin, dynamin, and amphiphysin (Rogat and Miller,
2002). The investment cone forms around each nucleus
and migrates down the cyst, powered by actin dynamics
(Noguchi and Miller, 2003), to the tip or apical region,
encompassing each spermatid in membrane and removing
excess cytoplasm in a structure surrounding the investment
cone called the cystic bulge (Tokuyasu et al., 1972a).
Although the process of individualization has been the
subject of recent study, less is known about the conditions
required for investment cone formation and coordination
with other components associated with the individualiza-
tion complex.
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MyoV mutant males to determine if there were morpho-
logical abnormalities in mutant testes. Testes from
MyoVQ1052st/CyO,GFP control males had visible elongated
cysts (Fig. 3A, arrow) and dark, sperm-filled seminal
vesicles (Fig. 3A, SV). Coiled sperm were visible in the SV
(Fig. 3C) and nuclear heads were seen by nucleic acidFig. 3. Morphology of MyoV mutant testes. DIC montages of unfixed testes from
mutant (MyoVQ1052st) males. Seminal vesicles (SV) are dark in the control testes a
arrows, scale bar = 50 Am. Confocal DIC (C and E) and fluorescence nucleic aci
heads can be seen in the control seminal vesicle (C and D). These are absent in the
fluorescence of MV (green) and actin (red) in control (G and I) and MyoV mutan
migration. (G) In controls, MVassociates with actin in investment cones in the term
toward the tip, MyoV staining was lost; arrowhead points to a migrating individu
MyoV staining is observed in the MyoV mutant and investment cones are disrupte
same magnification, scale bar = 50 Am; panels I and J are at the same magnificastaining (Fig. 3D). Motile sperm were observed when the
seminal vesicles of control males were opened. Many male
infertility mutations affect early stages of cyst development
including mitotic and meiotic divisions, as well as
cytokinesis (Castrillon et al., 1993; Wakimoto et al.,
2004). Therefore, we looked for these defects by exami-
nation of testes squashes by phase contrast microscopy(A) balanced control (MyoVQ1052st/CyO-GFP) and (B) homozygous MV
nd nearly transparent in the mutant. Fully elongated cysts are marked with
d staining (D and F). Coiled sperm and needle-shaped nuclei of the sperm
MV mutant seminal vesicle (E and F), scale bar = 15 Am. Confocal DIC and
t (H and J) testes, arrows show the direction of individualization complex
inal portion of the testes (term). As the individualization complex migrated
alization complex; (I) shows the terminal region of different testis. (H) No
d; (J) shows terminal region of a different testis. Panels G and H are at the
tion, scale bar = 25 Am.
Fig. 4. Model of MyoV distribution in cysts. The distributions of selected
cyst components at the terminal end of the testis are shown; one spermatid
of sixty-four is shown for simplicity. The cyst on the left shows
development of the pre-migration actin/nuclear assembly. MyoV staining
strongly overlaps the nucleus and slightly overlaps actin; cytoplasmic
microtubules are present. For simplicity, the syncytial cyst membrane is not
shown. The cyst on the right shows migration of the actin-based
individualization complex and the loss of cytoplasmic microtubules and
MyoV. The individual sperm membrane is present after the individualiza-
tion complex migrates past the nuclei.
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meiotic divisions in the mutant testes as well as the normal
arrangement of the nebenkern (mitochondrial derivative)
and nuclei (data not shown). These findings suggest that
the early stages of spermatogenesis were completed
normally in the MyoV mutant. Migration of sperm heads
to the terminal region was observed by nucleic acid
staining (data not shown) and elongated cysts were visible
in the mutants (Fig. 3B, arrow). However, in MyoV mutants
the seminal vesicles are nearly transparent (Fig. 3B, SV).
The SV in MyoV mutant males appeared empty by
differential interference contrast microscopy (Fig. 3E),
sperm heads were not visible (Fig. 3F), and no sperm
were observed when the seminal vesicles of mutant males
were opened. These observations revealed that MyoV
mutant males did not produce mature sperm. Since nuclear
divisions and cyst elongation appeared to be normal, we
focused our attention on the post-elongation stages of
spermatogenesis including individualization.
MyoV localization in whole testes
In order to understand the role of MyoV in spermato-
genesis, we determined the relationship between MyoV and
the structures known to be important for the post-
elongation stages of spermatogenesis in normal testes.
Immunolocalization in control (MyoVQ1052st/CyO,GFP)
testes revealed strong MyoV staining in the terminal one-
third of the testes (Fig. 3G, Term). In this region,
investment cones form in association with the sperm head
nuclei after cyst elongation. During the process of
individualization, investment cones move in register
(within the individualization complex, arrowhead in Fig.
3G) away from the nuclei toward the tip of the testes (Figs.
3G and H, direction indicated by arrows). Although the
distribution of MyoV slightly overlapped investment cone
actin, most MyoV was clustered at the narrow terminal
ends of the nuclei while individualization complexes
formed (Figs. 3G and I). During the process of individu-
alization, investment cones move in register (within the
individualization complex) away from the nuclei toward the
tip of the testes (Figs. 3G and H, direction indicated by
arrows). When individualization complexes began to move,
MyoV staining frequently appeared fragmented and was
lost (Figs. 3G and I). MyoV was not found associated with
individualization complexes that migrated out of the
terminal region (see Fig. 4 for summary). Given that
MyoV was not associated with individualization complexes
in the tipward two-thirds of the testes, it is unlikely that
MyoV is required for individualization complex movement
or to maintain the registry of individual investment cones
during individualization complex migration. In addition to
the strong staining at the terminal end of nuclei during
individualization complex formation, weaker, diffuse
MyoV staining was found throughout control cysts (Figs.
3G and I); however, this is likely background signal as faintdiffuse stain of cysts was also seen in some MyoV mutant
testes (Fig. 3J). The specificity of the anti-MyoV antibodies
was confirmed by the lack of strong staining in mutant
testes and other structures (Figs. 3H, J, and Supplemental
Fig. 2L).
Individualization complexes are disrupted in whole mutant
testes
To begin to understand the defects in spermatogenesis in
the MyoV mutants, we examined individualization complex
structure in whole MyoVQ1052st mutant testes by F-actin
staining. The individualization complexes in theses testes
were severely disrupted (Figs. 3H and J). The overall
amount of actin staining was reduced and although a few
cone-like actin structures were visible, no well-ordered
arrays of actin cones into individualization complexes were
observed. In addition, abnormal clumps of actin staining
were apparent in the terminal region of the mutant testes.
The apparent lack of normal individualization complexes in
the MyoV mutant was in contrast to the Drosophila myosin
VI mutant (jar) in which individualization complexes form
but breakdown after they begin migration (Hicks et al.,
1999).
MyoV associates with investment cones
Since MyoV was lost from the actin cones upon
individualization complex migration, we focused our
attention on the early development of this assembly in
control testes by examination of the distribution of MyoV,
F-actin, and DNA (Fig. 5). Immediately after cyst elonga-
tion, the elongated, partially condensed sperm head nuclei
Fig. 5. MyoV associates with the nuclei of nascent investment cones. Fluorescence images of DNA visualized with Hoechst (blue), actin (red) with phalloidin
and immunofluorescence of MyoV (green) in pre-individualization cysts from control males. In all panels the direction of individualization complex migration
(toward the tip) is up. (A and B) Extended spermatids with nuclei that are not fully condensed. Initially, actin staining is weak and wispy with no (A) or little
MV (arrows, B), as the nuclei become fully condensed, the intensity of actin and MyoV staining increases (C and D). When fully mature investment cones
separate from the nuclei, MyoV staining is rapidly lost (E). Scale bar = 5 Am.
V. Mermall et al. / Developmental Biology 286 (2005) 238–255 247were in the terminal region of the testes and were associated
with very little F-actin or MyoV (Fig. 5A). F-actin was
initially visible as thin wispy strands with faint MyoV
puncta at the terminal end of clustered nuclei (Fig. 5B). As
actin investment cones matured the nuclei fully condensed,
actin staining became thicker and more intense and was
accompanied by an increase in MyoV staining (Fig. 5C).
Interestingly, F-actin staining was more intense toward the
tip end of the nuclei (up in all panels) while MyoV staining
was more intense at the terminal end, away from the bulk ofthe F-actin. This organization was maintained as the F-actin
strands broadened at their tipward ends to begin to form
cones (Fig. 5D). When the investment cones migrated away
from the nuclei (which remain in the terminal region) MyoV
staining rapidly diminished (Fig. 5E and summarized in
Fig. 4). No MyoV co-localization was observed with nuclei
lacking associated F-actin; likewise, no MyoV staining was
observed with investment cones that migrated away from
nuclei. This is in contrast to myosin VI, which is found at
the tipward end of investment cones throughout their
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suggest that MyoV is primarily associated with the non-F-
actin component of the actin cone/nuclear assembly during
individualization complex maturation, and that MyoV
function was required prior to individualization complex
migration.
Investment cone formation was disrupted in the MyoV
mutant
To further assess the role of MyoV in investment cone
maturation, we examined F-actin and spermatid nuclei in
isolated cysts from MyoV mutant and control testes. In
controls, individual F-actin-containing investment cones
were in register within each individualization complex; the
same was true for nuclei (Fig. 6A). As noted above, very
few well-formed investment cones (and no individualiza-
tion complexes) were present in mutant testes (Figs. 3H, 3J,
6B–D, and 7C). Scattered individual investment cones and
nuclei were visible in some mutant testes, and some
investment cones had fully broadened (Fig. 7C). However,
when investment cones formed, they were few in number
and in poor registration with each other or with nuclei
(Figs. 6B–D). Additionally, when investment cones were
observed with nuclei in the mutant, they frequently failed toFig. 6. Investment cones are disrupted in the MyoV mutant. Confocal (A–C) or ep
actin (red) in dissected cysts. Row A is from control testes (two adjacent cysts are
arrays of spermatid nuclei and actin-based investment cones, arrow indicated the
fewer and less well-ordered actin strands than controls; scale bar = 10 Am.extend past those nuclei (Fig. 6, compare Figs. 6B–D with
A). We examined clusters of nuclei in the terminal testis
that had corresponding actin staining and scored for the
presence of strands of F-actin as well as extension of
investment cones past nuclei in control and mutant testis.
We scored 114 mutant nuclear clusters and found only 45
(35%) with F-actin strands and only 4 (3.5%) that showed
extension of actin past nuclei. We found no normal arrays
of actin-based investment cones in the mutant. In contrast,
of 144 control nuclear clusters, 76 (53%) were associated
with actin strands and 42 (29%) displayed actin staining
extended past the nuclei, forming the individualization
complex.
Mutations that cause nuclear shaping defects can also
affect investment cone formation (Fabrizio et al., 1998);
therefore, we examined nuclear structure by nucleic acid
staining of the MyoV mutant (Fig. 6B). Many nuclei in the
terminal region of the mutant testis were fully elongated,
and within a given cyst, substantially in register with each
other. Many nuclei also appeared fully condensed. Taken
together, these data suggest that nuclear migration to the
terminal region and maturation occur normally. Further-
more, investment cones begin to form in relation to nuclei,
although fewer in number than expected, and occasionally
mature into cones. However, the registration of individualifluorescence (D) micrographs of nucleic acid staining (DNA, green) and F-
show), rows B–D are from the MyoV mutant. Controls show well-ordered
direction of individualization complex movement. MyoV mutants produce
Fig. 7. Localization of MyoV and MyoVI are independent. Confocal images of MyoVI and/or MyoV immunofluorescence with phalloidin staining of F-
actin, all images are from the terminal third of the testis. Direction of investment cone migration in all images is up. (A) MyoV and MyoVI staining in
control (jar1/TM3) testes. MyoV concentrates at the terminal end of the nuclear/actin cone assembly, whereas MyoVI extends the length of the investment
cone. The region of overlap between the two myosins can be appreciated by comparing their distributions in the unmerged images. (B) MyoV
immunofluorescence in MyoVI mutant (jar1) testes. MyoV location is not disrupted. (C) MyoVI immunofluorescence in MyoV mutant (MyoVQ1052st) testes.
Although investment cones are severely disrupted, most investment cones maintained MyoVI localization to the broad end of the actin cone; asterisks
indicate investment cones without MyoVI staining. All scale bars = 5 Am.
V. Mermall et al. / Developmental Biology 286 (2005) 238–255 249investment cones within an individualization complex was
disrupted in the MyoV mutant.
Investment cone disruption may be a primary defect of
MyoV loss
Spermatids are coiled in the terminal region after
individualization; defective spermatids that do not properly
individualize are coiled, phagocytosed, and broken down
by the terminal epithelia cells (Tokuyasu et al., 1972b).
Coiled cysts were clearly visible in MyoV mutant testes
(Figs. 3B, H, and J). The disruption of investment cones
seen in mutant testes may be the remains of degrading,
defective spermatids. If the scattering of investment cones
were the product of defective spermatid breakdown, we
would expect the registration of both nuclei and actin to
be equally effected; however, the actin-based investment
cones were more disrupted in MyoV mutants than the
clusters of nuclei (Fig. 6). It is also important to note that
defects are seen early in the process of investment cone
formation, before actin broadens into cones and before
spermatid coiling and degradation (Fig. 6). This suggests
that at least some of the F-actin defects were a directresult of the loss of MyoV, and not simply spermatid
degradation.
Localization of MyoV and myosin VI were independent of
each other
Drosophila myosin VI (MyoVI) has been shown to be
required for spermatid individualization (Hicks et al., 1999).
MyoVI is present along the length of nascent investment
cones and concentrates at the leading edge of cones as they
migrate (Hicks et al., 1999, and Fig. 7A). In MyoVI mutants
(jar1) individualization complexes form and begin to
migrate, but rapidly fall apart. In control testes MyoV
concentrated in the terminal side of the nuclei and F-actin,
and MyoVI extended tipward past F-actin; however, there
was some overlap in the distribution of MyoV and MyoVI,
which is easily seen by comparing their distributions in the
unmerged images (Fig. 7A). If MyoV is involved in the
transport or anchoring of vesicles containing MyoVI, or
materials required for MyoVI localization, then MyoVI
localization could be impaired in the MyoV mutant and vice
versa. This is of particular relevance given the recent
demonstration that the localization of the minus end directed
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border is dependent on the plus-end motor myosin Ia (Tyska
et al., 2005). To explore this, we localized MyoV in jar
mutant testes. MyoV was correctly localized in homozygous
jar1 testes, demonstrating that MyoV localization does not
directly or indirectly depend on MyoVI (Fig. 7B). To
determine if MyoVI requires MyoV for its localization, we
stained for MyoVI in homozygous MyoVQ1052st testes.
Although investment cones were severely disrupted in the
example shown, MyoVI staining correctly localized to the
broad end of the cones (Fig. 7C). A few investment cones
lacked MyoVI staining (Fig. 7C, asterisks) and not all the
MyoVI puncta were associated with actin staining. How-
ever, these data indicate that MyoV was not absolutely
required for MyoVI localization.
MyoV co-localized with conA-labeled membranes and
microtubules
Prior to the start of individualization, many membrane
compartments contribute to spermatogenesis. Golgi-derived
membrane contributes to the acrosome in pre-elongation
Drosophila cysts (Lindsley and Tokuyasu, 1980), and the
axoneme is surrounded by an ER-derived membrane, the
axonemal sheath (Lindsley and Tokuyasu, 1980). In other
organisms class V myosins associate with Golgi-derived
proacrosomal vesicles (Kierszenbaum et al., 2004) and with
ER (Estrada et al., 2003; Takagishi et al., 1996). To
examine the association of MyoV with membranes, we
costained cysts for MyoV and fluorescently labeled con-
canavalin A (conA). In mature Drosophila sperm, conA
has been shown to strongly bind to the plasma membrane
over the acrosome (Perotti and Riva, 1988), which isFig. 8. MyoV associates with membranes and axonemes. Top row: immunof
concanavalin A (conA, red). Discreet MyoV puncta align with conA staining, b
immunofluorescence of MyoV (green) and microtubules (red) in cysts from contro
staining. Lower cyst shows strong MyoV staining at the terminal region of the cys
cyst shows a more tipward cyst region with weak MyoV staining in linear trackslocated at the terminal end of the nucleus. MyoV staining at
the terminal end of cysts was largely co-localized with
conA (Fig. 8, top row). Much of the conA and MyoV
staining was punctate and may represent vesicles, which
suggests that at least some of the MyoV protein in the
terminal region of testes was associated with vesicles.
Similar results were obtained when cysts were costained
with fluorescently conjugated wheat germ agglutinin and
MyoV (data not shown).
Previous studies demonstrated that cytoplasmic MTs
are present along the length of and at terminal end of
cysts prior to the start of individualization; however,
cytoplasmic MTs vanish when individualization starts as
determined by electron microscopy (Tokuyasu et al.,
1972a) and immunofluorescence (Noguchi and Miller,
2003). The loss of cytoplasmic MTs is roughly coincident
with the loss of MyoV from investment cones (summar-
ized in Fig. 4). Class V myosins have been found in
association with MTs in other systems and chicken
myosin V has been shown to directly bind to MTs (Cao
et al., 2004). Therefore, we looked for association
between Drosophila MyoV and MTs by costaining
isolated cysts for MyoV and a-tubulin. We found that
MyoV and tubulin staining overlapped at the terminal end
of cysts (Fig. 8, bottom row). Less intense MyoV staining
was also found in a long linear pattern associated with the
spermatid axoneme (Fig. 8, arrows in boxed region). The
observed staining may represent association with the
axonemal sheath; however, Drosophila MyoV may also
directly bind MTs.
Given the co-localization between MyoV and MTs, we
wished to determine if MyoV localization is dependent on
MTs. To determine if MT depolymerization affects MyoVluorescence of MyoV (green) and membrane detected with fluorescent
ut not all conA stain, was associated with MyoV. Bottom row: Confocal
l males. Areas within boxes have been LUT stretched to show fainter MyoV
t and weaker linear MyoV staining associated with tubulin stain. The upper
(arrows) associated with tubulin. Scale bar in both = 5 Am.
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destabilizing drug colchicine and then processed for MyoV
and a-tubulin immunofluorescence. Since cytoplasmic MTs
and MyoV vanish from cysts at the start of actin cone
migration, we staged cysts by assessing presence of pre-
migration investment cones by phalloidin staining or by
determining the state of nuclear condensation with Hoechst
staining. In cysts in which MyoV and cytoplasmic MTs
should be present, based on actin or nuclear morphology,
MyoV staining tracked closely with MT staining even
though the incubation and washes used in this experiment
caused some morphological perturbations (Fig. 9A). In
colchicine-treated cysts, the disruption of MTs varied;
however, in regions with highly disrupted MTs, MyoV
staining was generally diffuse (Figs. 9B and C). Where
MTs were not heavily disrupted, MyoV staining was
essentially unperturbed and was found in association with
tubulin staining. In a few cysts with highly disrupted
cytoplasmic MTs, MyoV staining was much less perturbed
than the MTs, suggesting that MyoV localization is
partially, but not completely dependent on cytoplasmic
MTs.Fig. 9. MyoV localization is partially dependent on microtubules. Fluorescent imag
in dissectedMyoVQ1052st/CyO-GFP cysts. All cysts are shown with the direction of
some morphological abnormalities, the control cyst demonstrates MyoV staining at
colchicine-treated cysts. Both microtubules and MyoV localization are severely dDiscussion
MyoV has been identified in a wide variety of species
and tissue types and has been implicated in a large number
of processes including the transport of mRNA and vesicles,
organelle inheritance and localization, and the establish-
ment/maintenance of cell polarity. However, determining
the role of a given MyoV is difficult in many organisms due
to the presence of multiple myosin V genes, each of which
may each encode multiple isoforms. Analysis of the
complete Drosophila melanogaster genome has revealed
the presence of only one class V myosin gene. This fact,
combined with the genetic tractability of this metazoan lead
to the hope that a MyoV mutation in Drosophila, would lead
to a clear picture of myosin V function.
We studied the expression and genetic requirements for
MyoV during development of D. melanogaster. The
developmental expression profile and localization of MyoV
revealed high levels of expression throughout development
and in egg chambers, testes, the gut, and CNS. We generated
two mutations in the MyoV gene and both mutants share the
same phenotype: striking developmental delays and sub-es of actin stained with phalloidin (blue), MyoV (green) and a-tubulin (red)
investment cone migration up. (A) Although treatment conditions produced
the terminal end of the cyst, with microtubule co-localization. (B and C) are
isrupted. Scale bar = 5 Am.
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embryos and in egg chambers, we present clear genetic
evidence that it is not required for oogenesis or embryo-
genesis. Despite larval lethality, some homozygous MyoV
mutant animals appear to develop normally and do not
display disruptions in organ or cellular architecture visible
by actin staining or by light microscopy; nor do these
animals demonstrate the neurological defects seen in MyoVa
mutant mice. It should be noted that without the dramatic
seizure defect leading to the fortuitous observation of
Purkinje cell defect in the dilute mouse (Takagishi et al.,
1996), the cause of lethality in that myosin V mutant might
be opaque as well. The essential function of MyoV in
Drosophila may have nothing to do with early development,
but with overall cellular health; thus, the lethality seen in
homozygous MyoVQ1052st larvae may be due to additive
cellular defects in the many tissues in which MyoV is
expressed. Although the essential function(s) of MyoV
remains to be determined, we can explore MyoV function
through the study of male infertility.
MyoV is required for investment cone formation and
individualization
In this study, we demonstrate that MyoV was required for
male fertility. The first clear defect in spermatogenesis in the
MyoV mutant appears to be in the actin component of the
nascent investment cones. Our results suggest that although
MyoV function was not absolutely required for investment
cone formation, MyoV may play a role in establishing or
stabilizing F-actin cones, as well as organizing the relation-
ship between components contributing to the individualiza-
tion complex. For example, MyoV may act as a structural
‘‘checkpoint’’ during spermatid nuclear maturation to hold
the nuclei in place during formation of the individualization
complex. A few other mutations have been characterized
that disrupt the individualization complex without profound
effects on the nuclear organization. These include mutations
in jaguar, the myosin VI gene (Hicks et al., 1999), and
mulet (Fabrizio et al., 1998). In both of these cases the
individualization complex appears normal initially, and then
breaks down after migration starts. However, we have never
observed normal individualization complexes in the
MyoVQ1052st mutant; together with the loss of MyoV from
the migrating investment cones in control animals, our data
suggest that MyoV is required for individualization, but
after spermatid elongation and before individualization
complex migration.
MyoV may mediate microtubule, vesicle, and actin
interactions
Class V myosins in other organisms are known to
interact with membranes (reviewed in Langford, 2002;
Reck-Peterson et al., 2000) and also have been shown to
mediate interactions between MT and F-actin arrays througheither direct (Cao et al., 2004) or indirect interactions with
MTs (Wu et al., 1998b; Yin et al., 2000). This includes the
recent demonstration that MyoV may mediate such inter-
actions during spermatogenesis in the mouse.
Myo5a localizes to the acroplaxome (Kierszenbaum et
al., 2003a) in mouse spermatids. The acroplaxome is an F-
actin and keratin-containing plate that links the developing
acrosome to the nuclear envelope; it is associated with
manchette MTs and Golgi-derived vesicles (Kierszenbaum
et al., 2003a,b, 2004). The manchette is a transient
microtubular-based structure that exists during the process
of elongation and condensation of the mammalian sperma-
tid nucleus (Fawcett et al., 1971). The acroplaxome,
acrosome, and manchette are thought to be required for
nuclear head shaping in mammalian sperm since mouse
mutants with disruptions in these structures produce round-
headed sperm (for a review, see Kierszenbaum and Tres,
2004). Myosin V and Rab 27 are also found with
manchette-associated Golgi-derived vesicles that contribute
to acrosome biogenesis (Kierszenbaum et al., 2004).
Drosophila contains an analogous array of MTs and
organelles in association with the sperm heads. However,
normally shaped nuclei are observed in the MyoV mutant,
indicating that maturation of sperm heads occurs independ-
ently of MyoV.
We have detected MyoV in association with puncta and
conA-labeled membrane, which suggests that Drosophila
MyoV associates with vesicles. Myosin V docking to
vesicles is mediated by Rab27 and its effectors in other
systems (Fukuda and Kuroda, 2002; Nagashima et al., 2002;
Strom et al., 2002; Wu et al., 2002). We have found Rab27
expression in Drosophila testes by RT-PCR (VM, unpub-
lished data) and the region of the myosin V tail domain
required for Rab27-mediated membrane interaction (Au and
Huang, 2002) is partially conserved in fly MyoV (VM,
unpublished data). Thus, the Rab/effector system for
docking MyoV to vesicles may function in testes.
MyoV vesicle transport may contribute components for
acrosome biogenesis and/or to the nascent individualization
complex. The work of Stanley et al. (1972) reveals some
key ultrastructural features of the acrosome in the develop-
ing Drosophila spermatid. In the caudal region of the
acrosome, the acrosome and nucleus lay side by side. A
band of intermediate electron density can be seen between
the acrosome and the nucleus (Figs. 24 and 44 of Stanley et
al., 1972). This structure may be analogous to the
acroplaxome described in mouse by Kierszenbaum et al.
(2003b). Also of interest is an array of fine fibrils that
extend from the acrosome to the plasma membrane (Fig. 24
of Stanley et al., 1972). The area around these fibrils is
devoid of vesicles and MTs; as chromatin condensation
progresses, the fibrils terminate in the cytoplasm near the
array of MTs that surrounds the nucleus and acrosome (Fig.
44 of Stanley et al., 1972). Although the composition of
these fibrils is unknown, they are the same diameter as actin
filaments and may represent a connection between the
V. Mermall et al. / Developmental Biology 286 (2005) 238–255 253acrosome, the actin cytoskeleton, and MTs. Importantly, the
area where the acrosome is found is the region where MyoV
staining is strong, and the presence of the fibrils provides
ultrastructural evidence for an anchor that may regulate
investment cone registration and/or movement. If, as in
mouse, MyoV-associated vesicles contribute to acrosome
biogenesis, we hope to detect defects in acrosome structure
in the MyoV mutant by ongoing electron microscopy
studies.
If MyoV-mediated transport is to the actin-based invest-
ment cones, MyoV may deliver components required for the
stabilization/organization of this complex. MyoV may also
function as a linker between the MT and actin cytoskeletal
systems, as suggested by the observed co-localization with
MTs in the testes. MyoV may mediate vesicle traffic
between MTs and actin in the investment cone by direct
transport, or by tethering vesicles to actin that have
undergone MT-mediated transport. MyoV may also cross
link MTs and actin, stabilizing the investment cone/
manchette assembly; the presence of fibrils extending from
the acrosome to MTs (Stanley et al., 1972) in the MyoV-rich
acrosomal region supports this idea. Such a cross linker may
function as a brake on investment cone movement until it is
mature, at which point both MyoVand cytoplasmic MTs are
no longer required.
The loss of MyoV immunoreactivity at the beginning of
investment cone movement suggests degradation of the
protein or release into the cytoplasm. Vertebrate class V
myosins contain a PEST site, which functions to target a
protein for degradation (Rechsteiner and Rogers, 1996;
Rogers et al., 1986); however, Drosophila MyoV does not.
The head domain of MyoV does contain a predicted Dcp-1
caspase cleavage site. The Dcp-1 caspase is activated by the
DRONC caspase and active DRONC is found in association
with individualization complexes and is required for
individualization (Huh et al., 2004). It is also possible that
a change in the phosphorylation state of MyoV will release
it from the individualization complex. Further dissection of
the failure of individualization complex construction in the
MyoV mutant will advance our understanding of the
coordination of MT, actin, and membrane systems in
dynamic processes by class V myosins.Acknowledgments
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